|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's Range||N/A - N/A|
|52 Week Range||undefined - undefined|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
NEW YORK , Nov. 9, 2017 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced Lombard Medical, Inc. (OTCQX: EVARF) ...
For Lombard Medical Inc’s (NASDAQ:EVAR) shareholders, and also potential investors in the stock, understanding how the stock’s risk and return characteristics can impact your portfolio is important. EVAR is exposedRead More...
Lombard Medical, Inc. , a developer, manufacturer and marketer of endovascular abdominal aortic aneurysm endovascular repair products, today announced the full commercial launch in Japan of its new low-profile IntelliFlex™ LP delivery system for the Aorfix™ AAA system.
If you are a shareholder in Lombard Medical Inc’s (NASDAQ:EVAR), or are thinking about investing in the company, knowing how it contributes to the risk and reward profile of yourRead More...
Lombard Medical, Inc. , a developer, manufacturer and marketer of endovascular aortic aneurysm repair products, today announced the appointment of Jonathan Hornsby as Vice President, Sales & Marketing, effective immediately.
Lombard Medical, Inc. , a developer, manufacturer and marketer of endovascular aortic aneurysm repair products, today announced completion of a restructuring following the implementation of its new strategy to focus sales efforts in the UK, Japan and China, and reduce operating and manufacturing costs in order to achieve cash flow breakeven in the near term.
Categories: Yahoo FinanceGet free summary analysis Lombard Medical, Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of Lombard Medical, Inc. – Endologix, Inc., LeMaitre Vascular, Inc., Cardiovascular Systems, Inc. and Boston Scientific Corporation (ELGX-US, LMAT-US, CSII-US and BSX-US) that have also reported for this period. ... Read more (Read more...)